6932 Share Price Performance
NT$0
-13.15 (-100.00%)
Price NT$0
Share Pricen/a
Mercury Biopharmaceutical Corporation Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
6932 Community Narratives
There are no narratives available yet.
There are no community narratives available.
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Mercury Biopharmaceutical Corporation Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
- -0.17
- 84.55%
- -28,696.34%
- 16.3%
About 6932
- Founded
- 2019
- Employees
- n/a
- CEO
- WebsiteView website
Mercury Biopharmaceutical Corporation engages in the development of drugs for unmet needs in Taiwan. The company develops StackDose platform, a drug development platform to produce new dosage forms with precise time-controlled dissolution, precise site absorption, and various dosage adjustments to enhance the bio-availability of active pharmaceutical ingredients to reduce the dosage of drugs and its side effects. It develops drugs for treating erectile dysfunction, pulmonary hypertension, sleep disorder, benign prostatic hyperplasia, angina pectoris, migraine, anti-hypertension, and analgesic. The company was founded in 2019 and is based in New Taipei City, Taiwan.
